116 related articles for article (PubMed ID: 8725898)
1. APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+.
Sulkava R; Kainulainen K; Verkkoniemi A; Niinistö L; Sobel E; Davanipour Z; Polvikoski T; Haltia M; Kontula K
Neurobiol Aging; 1996; 17(3):373-6. PubMed ID: 8725898
[TBL] [Abstract][Full Text] [Related]
2. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia.
Treves TA; Bornstein NM; Chapman J; Klimovitzki S; Verchovsky R; Asherov A; Veshchev IO; Korczyn AD
Alzheimer Dis Assoc Disord; 1996; 10(4):189-91. PubMed ID: 8939277
[TBL] [Abstract][Full Text] [Related]
3. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
Landén M; Thorsell A; Wallin A; Blennow K
J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):352-6. PubMed ID: 8890772
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.
Helisalmi S; Linnaranta K; Lehtovirta M; Mannermaa A; Heinonen O; Ryynänen M; Riekkinen P; Soininen H
Neurosci Lett; 1996 Feb; 205(1):61-4. PubMed ID: 8867021
[TBL] [Abstract][Full Text] [Related]
5. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients.
Scacchi R; De Bernardini L; Mantuano E; Donini LM; Vilardo T; Corbo RM
Neurosci Lett; 1995 Dec; 201(3):231-4. PubMed ID: 8786847
[TBL] [Abstract][Full Text] [Related]
7. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
8. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia.
Bétard C; Robitaille Y; Gee M; Tiberghien D; Larrivée D; Roy P; Mortimer JA; Gauvreau D
Neuroreport; 1994 Oct; 5(15):1893-6. PubMed ID: 7841371
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men.
Stengård JH; Pekkanen J; Sulkava R; Ehnholm C; Erkinjuntti T; Nissinen A
Acta Neurol Scand; 1995 Oct; 92(4):297-8. PubMed ID: 8848934
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia.
Kawamata J; Tanaka S; Shimohama S; Ueda K; Kimura J
J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1414-6. PubMed ID: 7964823
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
Polvikoski T; Sulkava R; Haltia M; Kainulainen K; Vuorio A; Verkkoniemi A; Niinistö L; Halonen P; Kontula K
N Engl J Med; 1995 Nov; 333(19):1242-7. PubMed ID: 7566000
[TBL] [Abstract][Full Text] [Related]
13. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians.
Souza DR; de Godoy MR; Hotta J; Tajara EH; Brandão AC; Pinheiro Júnior S; Tognola WA; dos Santos JE
Braz J Med Biol Res; 2003 Jul; 36(7):919-23. PubMed ID: 12845379
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease.
Lannfelt L; Lilius L; Nastase M; Viitanen M; Fratiglioni L; Eggertsen G; Berglund L; Angelin B; Linder J; Winblad B
Neurosci Lett; 1994 Mar; 169(1-2):175-8. PubMed ID: 8047277
[TBL] [Abstract][Full Text] [Related]
16. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia.
Rodriguez Martin T; Calella AM; Silva S; Munna E; Modena P; Chiesa R; Terrevazzi S; Ruggieri RM; Palermo R; Piccoli F; Confalonieri R; Tiraboschi P; Fragiacomo C; Quadri P; Lucca U; Forloni G
Dement Geriatr Cogn Disord; 2000; 11(5):239-44. PubMed ID: 10940674
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?
Guo Z; Fratiglioni L; Viitanen M; Lannfelt L; Basun H; Fastbom J; Winblad B
Am J Epidemiol; 2001 Feb; 153(3):225-31. PubMed ID: 11157409
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study.
Hofman A; Ott A; Breteler MM; Bots ML; Slooter AJ; van Harskamp F; van Duijn CN; Van Broeckhoven C; Grobbee DE
Lancet; 1997 Jan; 349(9046):151-4. PubMed ID: 9111537
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease.
Traykov L; Rigaud AS; Baudic S; Smagghe A; Boller F; Forette F
J Neurol Sci; 2002 Nov; 203-204():177-81. PubMed ID: 12417380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
